Imiquimod Cream
Product Images NDC 51672-4145

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 51672-4145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Imiquimod 01)

Chemical structure of Imiquimod, a topical cream active ingredient, showing its molecular arrangement with nitrogen-containing rings and attached side groups.*

FDA Label Image

Figure 1 (Imiquimod 02)

A flowchart showing patient enrollment and outcomes for Imiquimod Cream versus Vehicle in a clinical study with 209 total participants. It details numbers completing 16 weeks of treatment, withdrawal counts, clear vs. not clear outcomes, and follow-up results after 12 weeks, illustrating treatment efficacy and patient retention.*

FDA Label Image

Principal Display Panel (24 Packet Carton)

Packaging label for Imiquimod Cream USP, 5%, a topical dermatologic prescription drug. The label displays the product name prominently with strength, states 24 single-use packets of 0.25 g each, totaling 6 g per box. Label includes storage instructions, inactive ingredients listing, a barcode, and manufacturer information for Taro Pharmaceutical Industries, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.